Temi della conferenza
Initially sparked by COVID-19, renewed interest in lipid-based systems for delivery has now evolved. With an escalating clinical demand and the chance to commercialize lipid-based nanoparticles for novel applications and tissue delivery, the spotlight remains on delivery as the key to achieving clinical and commercial success, unlocking new therapeutic horizons.
Professional congress organizer (PCO)
Hanson Wade Group
Annotazioni
URL:
Brochure: https://go.evvnt.com/2315995-3?pid=4832
Speakers: Amey Bandekar, Associate Director, Sanofi, Ching Kim, Tye Director, Head, Nanoparticle, Sanofi, Daniel Tondera, Head, Biology, Pantherna Therapeutics, and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/2315995-2?pid=4832
Ms. Stephanie Nketia
CategorieMedicina General
